| Trade Names: | |
| Synonyms: | |
| Status: | Approved (1978) |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| ATC: | A11CC04 |
| UNII: | FXC9231JVH |
| InChI Key | GMRQFYUYWCNGIN-NKMMMXOESA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C27H44O3 |
| Molecular Weight | 416.65 |
| AlogP | 5.7 |
| Hydrogen Bond Acceptor | 3.0 |
| Hydrogen Bond Donor | 3.0 |
| Number of Rotational Bond | 6.0 |
| Polar Surface Area | 60.69 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 0.0 |
| Heavy Atoms | 30.0 |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Renal Insufficiency, Chronic | 4 | D051436 | ClinicalTrials |
| Diabetic Nephropathies | 3 | D003928 | ClinicalTrials |
| Adenomatous Polyposis Coli | 3 | D011125 | ClinicalTrials |
| Prostatic Neoplasms, Castration-Resistant | 3 | D064129 | ClinicalTrials |
| Osteoporosis | 3 | D010024 | ClinicalTrials |
| Fibroma | 3 | D005350 | ClinicalTrials |
| Osteopetrosis | 3 | D010022 | ClinicalTrials |
| Pancreatic Neoplasms | 2 | D010190 | ClinicalTrials |
| Lupus Erythematosus, Systemic | 2 | D008180 | ClinicalTrials |
| Dermatitis, Atopic | 2 | D003876 | ClinicalTrials |
| Diabetes Mellitus, Type 1 | 2 | D003922 | ClinicalTrials |
| Breast Neoplasms | 2 | D001943 | ClinicalTrials |
| Hypertension | 2 | D006973 | ClinicalTrials |
| Acute Kidney Injury | 2 | D058186 | ClinicalTrials |
| Myelodysplastic Syndromes | 2 | D009190 | ClinicalTrials |
| Prostatic Neoplasms | 2 | D011471 | ClinicalTrials |
| Carcinoma, Basal Cell | 2 | D002280 | ClinicalTrials |
| Cholangiocarcinoma | 2 | D018281 | ClinicalTrials |
| Sepsis | 2 | D018805 | ClinicalTrials |
| Klinefelter Syndrome | 2 | D007713 | ClinicalTrials |
| Chronic Kidney Disease-Mineral and Bone Disorder | 2 | D012080 | ClinicalTrials |
| Breast Neoplasms | 2 | D001943 | ClinicalTrials |
| Osteoporosis, Postmenopausal | 1 | D015663 | ClinicalTrials |
| Melanoma | 1 | D008545 | ClinicalTrials |
| Central Nervous System Neoplasms | 1 | D016543 | ClinicalTrials |
| Neoplasms | 1 | D009369 | ClinicalTrials |
| Prediabetic State | 1 | D011236 | ClinicalTrials |
| Crohn Disease | 1 | D003424 | ClinicalTrials |
| Carcinoma, Non-Small-Cell Lung | 1 | D002289 | ClinicalTrials |
| Attention Deficit Disorder with Hyperactivity | 1 | D001289 | ClinicalTrials |
| Mouth Neoplasms | 1 | D009062 | ClinicalTrials |
| Familial Hypophosphatemic Rickets | 0 | D053098 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 32222-06-3 |
| ChEBI | 17823 |
| ChEMBL | CHEMBL846 |
| DrugBank | DB00136 |
| DrugCentral | 466 |
| EPA CompTox | DTXSID5022722 |
| FDA SRS | FXC9231JVH |
| Human Metabolome Database | HMDB0001903 |
| Guide to Pharmacology | 2779 |
| KEGG | C01673 |
| PDB | VDX |
| PubChem | 5280453 |
| SureChEMBL | SCHEMBL3245 |
| ZINC | ZINC000100015048 |